Cargando…
Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience
INTRODUCTION: Allogeneic hematopoietic stem cell transplantation offers the opportunity for extended survival in patients with Hodgkin's and non-Hodgkin lymphomas who relapsed after, or were deemed ineligible for, autologous transplantation. This study reports the cumulative experience of a sin...
Autores principales: | Massoud, Mira Romany, Caimi, Paolo Fabrizio, Ferrari, Nicole, Fu, Pingfu, Creger, Richard, Fox, Robert, Carlson-Barko, Joanne, Kolk, Merle, Brister, Lauren, Cooper, Brenda Wimpfheimer, Gerson, Stanton, Lazarus, Hillard Michael, de Lima, Marcos, William, Basem Magdy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119668/ https://www.ncbi.nlm.nih.gov/pubmed/27863759 http://dx.doi.org/10.1016/j.bjhh.2016.07.003 |
Ejemplares similares
-
Transmission of lupus anticoagulant by allogeneic stem cell transplantation
por: Massoud, Mira Romany, et al.
Publicado: (2014) -
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies
por: Caimi, Paolo F., et al.
Publicado: (2017) -
Prospective Study of Single vs. Two Unit Umbilical Cord Blood Transplantation Following Reduced Intensity Conditioning in Adults with Hematologic Malignancies
por: Kindwall-Keller, Tamila L., et al.
Publicado: (2011) -
Epigenetic therapy in allogeneic hematopoietic stem cell
transplantation
por: Bashir, Qaiser, et al.
Publicado: (2013) -
Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia
por: Ueda, Masumi, et al.
Publicado: (2020)